ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2191

Intestinal Microbiome In Polyarticular Juvenile Idiopathic Arthritis: A PILOT Study

Petra C.E. Hissink Muller1,2, A.E. Budding3, Cornelia F. Allaart4, Danielle M.C. Brinkman1,5, Taco W. Kuijpers6, Michiel Westedt1, J. Merlijn van den Berg7, Lisette W.A. Van Suijlekom-Smit8, Marion A.J. Van Rossum9, Tim G.J. de Meij10 and Rebecca Ten Cate1, 1Pediatric Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Pediatric Rheumatology, Reade Institute, Amsterdam, Netherlands, 3Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, Netherlands, 4Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5Pediatric Rheumatology, Rijnland Hospital, Leiderdorp, Netherlands, 6Pediatric Rheumatology and Immunology, Emma Children's Hospital/Academic Medical Center (AMC), Amsterdam, Netherlands, 7Department of Pediatric Rheumatology and Immunology, Emma Children's Hospital / Academic Medical Center (AMC), Amsterdam, Netherlands, 8Pediatric Rheumatology, Erasmus MC Sophia Children's Hospital, Rotterdam, Netherlands, 9Department of Pediatric Rheumatology and Immunology, Emma Children's Hospital / Academic Medical Center and Reade Institute, Amsterdam, Netherlands, 10Pediatric Gastroenterology, VU University Medical Center, Amsterdam, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: juvenile idiopathic arthritis (JIA), microbiome and polyarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Pediatric Rheumatology - Pathogenesis and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The intestinal microbiome may play a role in the pathogenesis of Juvenile Idiopathic Arthritis (JIA). In IBD patients an overall decrease in microbial diversity of the intestinal microbiota has been observed. Studies comparing intestinal microbiome in children with JIA and healthy controls have not been conducted to date. Therefore we analyzed and compared the composition and diversity of the distal colon associated microbiome between children with Disease-Modyfying-Anti-Rheumatic-Drug (DMARD) naive JIA and healthy controls and tried to identify specific gut bacteria associated with polyarticular JIA before initiation of a DMARD.

Methods: Total microbiome profile in stools of 8 children with DMARD naive polyarticular JIA were analyzed by means of IS-pro, a 16S-23S interspacer (IS) region-based profiling method and compared to stools of 24 age-matched healthy controls.

Results:

Faeces of 8 (6 girls, 2 boys) children with polyarticular JIA, all rheumatoid factor negative were investigated and compared to 24 healthy controls. Anti-Nuclear Antibodies were positive in 3 patients. Median age at evaluation was 11.1 years (7.3-13.1), median period from start complaints to diagnosis was 7.1 months (4.4-13.2). Median ACR pedi scores were: VAS physician 47mm(32-58), VAS patient well-being 32mm(27-52), ESR 8mm(2-9), active joint count 10(7-14), limited joint count 2 (0-4), CHAQ score 1.2 (0.4-1.7).

One intra-articular steroid injection was given to each of two patients respectively 1 and 4 months prior to stool collection. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) were used by all patients at the time of evaluation. Median age of the healthy controls was 10.6 years (8.4-12.9).

Median Simpson reciprocal index within phylum of Firmicutes is significantly lower in children with JIA (6.0) compared to controls (8.0) (p<0,012). (figure 1). Diversity within the phyla Bacteriodetes and Proteobacteria did not differ between the 2 subgroups. By constructing a Pearson-correlation dendogram, no clustering was seen between the JIA group and the healthy controls on species-level (figure 2), a specific JIA associated microbiotal signature could not be identified.

Conclusion: Intestinal microbiome diversity within the phylum Firmicutes was significantly lower between children with DMARD naive polyarticular JIA and healthy controls. An overall decrease in microbial diversity of the intestinal microbiota has also been observed in IBD patients. Whether intestinal dysbiosis plays a role in the pathogenesis of JIA remains subject of further studies.


Disclosure:

P. C. E. Hissink Muller,

Pfizer Inc,

2;

A. E. Budding,
None;

C. F. Allaart,
None;

D. M. C. Brinkman,
None;

T. W. Kuijpers,
None;

M. Westedt,
None;

J. M. van den Berg,
None;

L. W. A. Van Suijlekom-Smit,
None;

M. A. J. Van Rossum,
None;

T. G. J. de Meij,
None;

R. Ten Cate,

Pfizer Inc,

2.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/intestinal-microbiome-in-polyarticular-juvenile-idiopathic-arthritis-a-pilot-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology